FANCI expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.327800E-01
Normal-vs-Stage2
4.126600E-01
Normal-vs-Stage3
7.549800E-01
Normal-vs-Stage4
9.681200E-01
Stage1-vs-Stage2
4.578200E-01
Stage1-vs-Stage3
3.956800E-01
Stage1-vs-Stage4
6.879600E-01
Stage2-vs-Stage3
2.090400E-01
Stage2-vs-Stage4
3.634400E-01
Stage3-vs-Stage4
5.996000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.526800E-01
Normal-vs-AfricanAmerican
7.454000E-01
Normal-vs-Asian
4.625400E-01
Caucasian-vs-AfricanAmerican
5.415200E-01
Caucasian-vs-Asian
5.837000E-01
AfricanAmerican-vs-Asian
4.478800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.839600E-01
Normal-vs-Female
4.515600E-01
Male-vs-Female
5.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.936000E-01
Normal-vs-Age(41-60Yrs)
4.206800E-01
Normal-vs-Age(61-80Yrs)
4.911200E-01
Normal-vs-Age(81-100Yrs)
3.938800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.231200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.961000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.789600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.446420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.567200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.502400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.011000E-01
Normal-vs-Daily Drinker
5.015000E-01
Normal-vs-Weekly Drinker
4.981800E-01
Normal-vs-Occasional Drinker
4.970400E-01
Normal-vs-Social Drinker
3.994400E-01
Non Drinker-vs-Daily Drinker
6.387200E-01
Non Drinker-vs-Weekly Drinker
7.511600E-01
Non Drinker-vs-Occasional Drinker
6.596400E-01
Non Drinker-vs-Social Drinker
7.024400E-01
Daily Drinker-vs-Weekly Drinker
5.320600E-01
Daily Drinker-vs-Occasional Drinker
9.973400E-01
Daily Drinker-vs-Social Drinker
9.013600E-01
Weekly Drinker-vs-Occasional Drinker
5.356600E-01
Weekly Drinker-vs-Social Drinker
5.804000E-01
Occasional Drinker-vs-Social Drinker
9.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.970600E-01
Normal-vs-Grade 2
6.562600E-01
Normal-vs-Grade 3
6.785600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.899800E-03
Grade 1-vs-Grade 3
1.297500E-03
Grade 1-vs-Grade 4
5.970600E-01
Grade 2-vs-Grade 3
3.476000E-01
Grade 2-vs-Grade 4
6.562600E-01
Grade 3-vs-Grade 4
6.785600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.462400E-01
Normal-vs-NonDiabetic
4.393800E-01
Diabetic-vs-NonDiabetic
2.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.475000E-01
Normal-vs-NoPancreatitis
5.096600E-01
Pancreatitis-vs-NoPancreatitis
6.110200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.887600E-01
Normal-vs-N1
4.321200E-01
N0-vs-N1
7.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.452610E-01
Normal-vs-TP53-NonMutant
5.564600E-01
TP53-Mutant-vs-TP53-NonMutant
1.820170E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
